SCHEMBL4127331

SCHEMBL4127331

CC1(C)Oc2ccc(CN3C(=O)/C(=C/c4cccc(O)c4)SC3=S)cc2O1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.67
▸ KMT2A Q03164 10/20 0.67
▸ ATM Q13315 2/20 0.67
▸ POLB P06746 7/20 0.51
▸ PTPN1 P18031 4/20 0.51
▸ MAPK1 P28482 3/20 0.51
▸ CASP3 P42574 2/20 0.51
▸ SENP8 Q96LD8 2/20 0.51
▸ SENP7 Q9BQF6 2/20 0.51
▸ SENP6 Q9GZR1 2/20 0.51
▸ GAA P10253 2/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ ACP1 P24666 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ PSMD14 O00487 1/20 0.50
▸ HSD17B3 P37058 1/20 0.49
▸ DUSP22 Q9NRW4 1/20 0.49
▸ USP2 O75604 1/20 0.48
▸ GALK1 P51570 1/20 0.48
▸ BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4127335 1.00 MEN1 (0.67) MEN1KMT2AATMPOLBPTPN1
SCHEMBL4129724 0.91 MEN1 (0.68) MEN1KMT2AATMPOLBPTPN1
SCHEMBL4129730 0.91 MEN1 (0.68) MEN1KMT2AATMPOLBPTPN1
SCHEMBL4141542 0.86 MAPK1 (0.53) MEN1KMT2AATMPOLBMAPK1
SCHEMBL13651175 0.86 MAPK1 (0.53) MEN1KMT2AATMPOLBMAPK1
SCHEMBL4141548 0.86 MAPK1 (0.53) MEN1KMT2AATMPOLBMAPK1
SCHEMBL4125372 0.85 MEN1 (0.69) MEN1KMT2AATMPOLBPTPN1
SCHEMBL4125376 0.85 MEN1 (0.69) MEN1KMT2AATMPOLBPTPN1
SCHEMBL4125367 0.85 MEN1 (0.69) MEN1KMT2AATMPOLBPTPN1
SCHEMBL14220353 0.84 MEN1 (0.66) MEN1KMT2AATMPOLBPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MEN1 2336/4885KMT2A 1459/4885ATM 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback